Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00582582 · ClinicalTrials.gov registry record · Phase 2
Study of Docetaxel With Doxercalciferol or Placebo for Advanced Prostate Cancer
A Phase 2 study, sponsored by University of Wisconsin, Madison.
- Terminated
- Registry status
- Phase 2
- Development phase
- 70
- Enrollment target
NCT00582582: Clinical Trial Phase 2 study, sponsored by University of Wisconsin, Madison.
NCT00582582 is a Phase 2 study that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 70 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (47% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00582582, a Phase 2 study, was terminated before completion, sponsored by University of Wisconsin, Madison.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 70 participants
- Enrollment target
Study Summary
The purpose of this research study is to find out the toxicities of doxercalciferol given in combination with docetaxel (Taxotere®), as well as to see how well this combination works in the treatment of prostate cancer.
Interventions
- DRUG Docetaxel plus doxercalciferol
- DRUG Docetaxel plus placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2002-04 |
| Est. Completion | 2007-04 |
| Phase | Phase 2 |
Why NCT00582582 stopped before completion
NCT00582582 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (47% lower).
The record links to 0 conditions, and to 2 interventions - of which Docetaxel plus doxercalciferol is the first listed.
NCT00582582 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00582582 about?
NCT00582582 is a clinical study titled "Study of Docetaxel With Doxercalciferol or Placebo for Advanced Prostate Cancer". The purpose of this research study is to find out the toxicities of doxercalciferol given in combination with docetaxel (Taxotere®), as well as to see how well this combination works in the treatment of prostate cancer.
What is the current status of trial NCT00582582?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 70 participants. The study started on 2002-04. Estimated completion is 2007-04.
What interventions are being tested in trial NCT00582582?
The interventions under investigation include: Docetaxel plus doxercalciferol (DRUG), Docetaxel plus placebo (DRUG).
Who is sponsoring clinical trial NCT00582582?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00582582's enrollment target sits among peer trials
70 937th of 2000 higher than 1,036 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia